Logo image of PSAT.PA

PASSAT (PSAT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:PSAT - FR0000038465 - Common Stock

4.36 EUR
+0.01 (+0.23%)
Last: 9/30/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PSAT. PSAT was compared to 12 industry peers in the Broadline Retail industry. While PSAT seems to be doing ok healthwise, there are quite some concerns on its profitability. PSAT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PSAT had positive earnings in the past year.
In the past year PSAT has reported a negative cash flow from operations.
In the past 5 years PSAT has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: PSAT reported negative operating cash flow in multiple years.
PSAT.PA Yearly Net Income VS EBIT VS OCF VS FCFPSAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

PSAT has a Return On Assets of 1.68%. This is in the lower half of the industry: PSAT underperforms 71.43% of its industry peers.
With a Return On Equity value of 2.77%, PSAT is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
PSAT has a Return On Invested Capital (3.76%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for PSAT is below the industry average of 8.99%.
Industry RankSector Rank
ROA 1.68%
ROE 2.77%
ROIC 3.76%
ROA(3y)3.75%
ROA(5y)3.66%
ROE(3y)5.84%
ROE(5y)5.33%
ROIC(3y)6.18%
ROIC(5y)6.63%
PSAT.PA Yearly ROA, ROE, ROICPSAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

PSAT has a Profit Margin of 1.84%. This is in the lower half of the industry: PSAT underperforms 71.43% of its industry peers.
In the last couple of years the Profit Margin of PSAT has declined.
With a Operating Margin value of 4.43%, PSAT is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
PSAT's Operating Margin has declined in the last couple of years.
The Gross Margin of PSAT (57.77%) is better than 85.71% of its industry peers.
In the last couple of years the Gross Margin of PSAT has remained more or less at the same level.
Industry RankSector Rank
OM 4.43%
PM (TTM) 1.84%
GM 57.77%
OM growth 3Y-10.04%
OM growth 5Y-4.36%
PM growth 3Y-1.4%
PM growth 5Y-17.24%
GM growth 3Y1.53%
GM growth 5Y0.6%
PSAT.PA Yearly Profit, Operating, Gross MarginsPSAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

PSAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PSAT has less shares outstanding
PSAT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PSAT is higher compared to a year ago.
PSAT.PA Yearly Shares OutstandingPSAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
PSAT.PA Yearly Total Debt VS Total AssetsPSAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.97 indicates that PSAT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.97, PSAT is doing worse than 71.43% of the companies in the same industry.
PSAT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
PSAT has a Debt to Equity ratio of 0.20. This is amongst the best in the industry. PSAT outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 2.97
ROIC/WACC0.48
WACC7.86%
PSAT.PA Yearly LT Debt VS Equity VS FCFPSAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 3.33 indicates that PSAT has no problem at all paying its short term obligations.
PSAT has a Current ratio of 3.33. This is in the better half of the industry: PSAT outperforms 78.57% of its industry peers.
PSAT has a Quick Ratio of 2.28. This indicates that PSAT is financially healthy and has no problem in meeting its short term obligations.
PSAT has a Quick ratio of 2.28. This is in the better half of the industry: PSAT outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 2.28
PSAT.PA Yearly Current Assets VS Current LiabilitesPSAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

PSAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.28%.
Measured over the past years, PSAT shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.94% on average per year.
Looking at the last year, PSAT shows a decrease in Revenue. The Revenue has decreased by -2.55% in the last year.
PSAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.13% yearly.
EPS 1Y (TTM)-47.28%
EPS 3Y14.36%
EPS 5Y-7.94%
EPS Q2Q%-10.54%
Revenue 1Y (TTM)-2.55%
Revenue growth 3Y15.78%
Revenue growth 5Y11.13%
Sales Q2Q%-1.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PSAT.PA Yearly Revenue VS EstimatesPSAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.03, PSAT is valued correctly.
85.71% of the companies in the same industry are more expensive than PSAT, based on the Price/Earnings ratio.
PSAT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.60.
Industry RankSector Rank
PE 15.03
Fwd PE N/A
PSAT.PA Price Earnings VS Forward Price EarningsPSAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PSAT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.13
PSAT.PA Per share dataPSAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PSAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PASSAT

EPA:PSAT (9/30/2025, 7:00:00 PM)

4.36

+0.01 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.31M
Revenue(TTM)62.33M
Net Income(TTM)1.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.03
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.5
EV/EBITDA 1.13
EPS(TTM)0.29
EY6.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS14.84
BVpS9.83
TBVpS8.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.68%
ROE 2.77%
ROCE 5.45%
ROIC 3.76%
ROICexc 6.45%
ROICexgc 7.56%
OM 4.43%
PM (TTM) 1.84%
GM 57.77%
FCFM N/A
ROA(3y)3.75%
ROA(5y)3.66%
ROE(3y)5.84%
ROE(5y)5.33%
ROIC(3y)6.18%
ROIC(5y)6.63%
ROICexc(3y)11.28%
ROICexc(5y)12.99%
ROICexgc(3y)12.56%
ROICexgc(5y)14.63%
ROCE(3y)8.95%
ROCE(5y)9.61%
ROICexgc growth 3Y-6.11%
ROICexgc growth 5Y-9.64%
ROICexc growth 3Y-8.19%
ROICexc growth 5Y-9.07%
OM growth 3Y-10.04%
OM growth 5Y-4.36%
PM growth 3Y-1.4%
PM growth 5Y-17.24%
GM growth 3Y1.53%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 1.6
Cap/Depr 93.3%
Cap/Sales 3.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 2.28
Altman-Z 2.97
F-Score3
WACC7.86%
ROIC/WACC0.48
Cap/Depr(3y)83.8%
Cap/Depr(5y)95.29%
Cap/Sales(3y)2.98%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.28%
EPS 3Y14.36%
EPS 5Y-7.94%
EPS Q2Q%-10.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.55%
Revenue growth 3Y15.78%
Revenue growth 5Y11.13%
Sales Q2Q%-1.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.45%
EBIT growth 3Y4.16%
EBIT growth 5Y6.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-137.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.15%
OCF growth 3YN/A
OCF growth 5YN/A

PASSAT / PSAT.PA FAQ

Can you provide the ChartMill fundamental rating for PASSAT?

ChartMill assigns a fundamental rating of 3 / 10 to PSAT.PA.


What is the valuation status for PSAT stock?

ChartMill assigns a valuation rating of 2 / 10 to PASSAT (PSAT.PA). This can be considered as Overvalued.


Can you provide the profitability details for PASSAT?

PASSAT (PSAT.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of PASSAT (PSAT.PA) stock?

The Price/Earnings (PE) ratio for PASSAT (PSAT.PA) is 15.03 and the Price/Book (PB) ratio is 0.44.